Old Web
English
Sign In
Acemap
>
authorDetail
>
Yisong Xiong
Yisong Xiong
Medicine
Immunology
Refractory
Phases of clinical research
CAR T-cell therapy
3
Papers
47
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment of CML-transformed B Cell Acute Lymphoblastic Leukemia (B-ALL) in Adults with Anti-CD19 Chimeric Antigen Receptor T Cell (CAR T) Therapy.
2020
Stem Cell Reviews and Reports
Fang Liu
Sha Sha
Gina Ma
Yi Su
Yisong Xiong
Guangcui He
Yecheng Li
William M. Hanes
William Tse
Show All
Source
Cite
Save
Citations (0)
First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction
2019
Blood
Fang Liu
Hongyu Zhang
Xiao Wang
Yisong Xiong
Yuanzhen Cao
Yi Su
Hai Yi
Jia Feng
Wen-li Zhang
Yu Ma
Masayuki Wada
Yupo Ma
Show All
Source
Cite
Save
Citations (2)
First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial
2018
Blood
Fang Liu
Yuanzhen Cao
Kevin G. Pinz
Yu Ma
Masayuki Wada
Kevin Chen
Gina Ma
Jiaqi Shen
Charlotte Olivia Tse
Yi Su
Yisong Xiong
Guangcui He
Yecheng Li
Yupo Ma
Show All
Source
Cite
Save
Citations (45)
1